Can Vitamin C reduces COVID-19 symptoms

Phase 4

Recruiting

Conditions: Coronavirus as the cause of diseases classified elsewhere,

Registration Number: CTRI/2020/10/028695

Brief Summary: This prospective randomised controlled trial will be started after the ethical committee approval .Oral Vitamin C 500mg b.d will be given to symptomatic cove positive patients and reduction in severity and duration symptoms like fever cough and shortness of breath (dyspnea) will be observed.

Detailed Description: Not available

Recruitment & Eligibility

Status: Open to Recruitment

Sex: All

Target Recruitment: 100

Inclusion Criteria

Age more than 18years , COVID-19 positive(RT-PCR) either sex Symptomatic patient(fever, cough and breathing difficulty).

Exclusion Criteria

1.History of allergy to vitamin C 2.Pregnant females or breastfeeding mothers 3.Critical ill patient who are intubation and on mechanical ventilation.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement in illness can be assessed reduction in the grading (mild,moderate sever) of symptoms after l administration of vitamin C (5oomg, twice a day) in COVID19 patients.	maximum time is 14 days

Secondary Outcome Measures

Name	Time	Method
2.To assess the effect on duration of illness by oral administration of vitamin C (500mg, twice a day) in COVID-19 patients

Trial Locations

Locations (1): National Cancer Institute Jhajjar
🇮🇳
Jhajjar, HARYANA, India
National Cancer Institute Jhajjar
🇮🇳Jhajjar, HARYANA, India
Dr Balbir Kumar
Principal investigator
7006582855
drbalbir10@gmail.com